Review



mouse striata  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Thermo Fisher mouse striata
    Mouse Striata, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse striata/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    mouse striata - by Bioz Stars, 2026-06
    99/100 stars

    Images



    Similar Products

    99
    Thermo Fisher mouse striata
    Mouse Striata, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse striata/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    mouse striata - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc embryonic day-14 mouse striata neurospheres
    (A) BrdU (purple) and DAPI (blue) immunofluorescent staining of cultured adherent embryonic neural stem cells after 24 h BrdU exposure and treatment with a. PBS as vehicle, b. 20 ng/ml rhEGF as positive control and increasing doses of rmMFG-E8; c. 125 ng/ml, d. 250 ng/ml and e. 500 ng/ml. Quantification of the number of proliferating adherent embryonic stem cells (BrdU + ) showed that rmMFG-E8 increased embryonic neural stem cell proliferation in a dose-dependent manner compared with PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; #p<0.05 vs rhEGF; n = 3/group. (B) rhEGF (20 ng/ml) and rmMFG-E8 (500 ng/ml) increased neurosphere formation compared to PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; n = 3/group. Scale bar = 100 μm. (C) rmMFG-E8 treatment showed significant increase in the number of <t>neurospheres</t> in the <0.5 mm size categories compared to PBS. *p<0.05 vs PBS; n = 3/group.
    Embryonic Day 14 Mouse Striata Neurospheres, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/embryonic day-14 mouse striata neurospheres/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    embryonic day-14 mouse striata neurospheres - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc mouse e14.5 striata neural stem cells (neurospheres)
    (A) BrdU (purple) and DAPI (blue) immunofluorescent staining of cultured adherent embryonic neural stem cells after 24 h BrdU exposure and treatment with a. PBS as vehicle, b. 20 ng/ml rhEGF as positive control and increasing doses of rmMFG-E8; c. 125 ng/ml, d. 250 ng/ml and e. 500 ng/ml. Quantification of the number of proliferating adherent embryonic stem cells (BrdU + ) showed that rmMFG-E8 increased embryonic neural stem cell proliferation in a dose-dependent manner compared with PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; #p<0.05 vs rhEGF; n = 3/group. (B) rhEGF (20 ng/ml) and rmMFG-E8 (500 ng/ml) increased neurosphere formation compared to PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; n = 3/group. Scale bar = 100 μm. (C) rmMFG-E8 treatment showed significant increase in the number of <t>neurospheres</t> in the <0.5 mm size categories compared to PBS. *p<0.05 vs PBS; n = 3/group.
    Mouse E14.5 Striata Neural Stem Cells (Neurospheres), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse e14.5 striata neural stem cells (neurospheres)/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    mouse e14.5 striata neural stem cells (neurospheres) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Charles River Laboratories p0-p1 icr (cd-1) mouse striata
    (A) BrdU (purple) and DAPI (blue) immunofluorescent staining of cultured adherent embryonic neural stem cells after 24 h BrdU exposure and treatment with a. PBS as vehicle, b. 20 ng/ml rhEGF as positive control and increasing doses of rmMFG-E8; c. 125 ng/ml, d. 250 ng/ml and e. 500 ng/ml. Quantification of the number of proliferating adherent embryonic stem cells (BrdU + ) showed that rmMFG-E8 increased embryonic neural stem cell proliferation in a dose-dependent manner compared with PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; #p<0.05 vs rhEGF; n = 3/group. (B) rhEGF (20 ng/ml) and rmMFG-E8 (500 ng/ml) increased neurosphere formation compared to PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; n = 3/group. Scale bar = 100 μm. (C) rmMFG-E8 treatment showed significant increase in the number of <t>neurospheres</t> in the <0.5 mm size categories compared to PBS. *p<0.05 vs PBS; n = 3/group.
    P0 P1 Icr (Cd 1) Mouse Striata, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p0-p1 icr (cd-1) mouse striata/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    p0-p1 icr (cd-1) mouse striata - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Charles River Laboratories mouse striata
    Studies with Cx3cr1 -/- mice: Fluorescent images and effects of Cx3cr1 -/- glia on fractalkine-mediated neuroprotection . Images of the striatum (A-C) and of mixed glial cultures (D) from Cx3cr1 -/- mouse <t>striata.</t> <t>Microglia</t> within the striatum of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice fluoresce green (A,B) and are Iba-1 immunoreactive (C); Hoechst counterstained nuclei (blue); scale bars = 50 μm (A) and 10 μm (B,C). Robust GFP expression is maintained when the cells are placed into culture (D). As can be appreciated from the Hoechst stain, the CX 3 CR1-expressing population is significant although the majority of the cells in the culture lack CX 3 CR1. The loss of CX 3 CR1 on glia has a dramatic effect on the ability of fractalkine to protect morphine and Tat-treated striatal neurons (E). Neurons from the striata of wild-type mice were plated onto mixed glia prepared from Cx3cr1 -/- mouse striata and followed over 48 h using our standard paradigm. In general, wild-type neurons co-cultured with Cx3cr1 -/- glia appeared to be less viable than with wild-type glia (upper panel; compare gray and black dotted lines); however, these groups were not compared statistically since the experiments were not run concurrently. The neuroprotective effects of fractalkine (CX 3 CL1; 1 μg/ml) are abolished when wild-type neurons are co-cultured with Cx3cr1 -/- mixed glia. Under these conditions, fractalkine no longer protects neurons from combined morphine and Tat exposure (E, lower panel; * P < 0.05 vs. vehicle- or fractalkine-treated controls). There were no differences in survival between controls ± fractalkine. Addition of fractalkine did not change the toxicity of morphine, Tat, or morphine + Tat treatments. There is, however, some possibility that fractalkine enhances baseline neuron survival in the Cx3cr1 -/- glial co-cultures. This was indicated by significant differences only at 48 h between Tat + fractalkine versus control + fractalkine survival ( § P < 0.05), even though survival did not differ when comparing vehicle + control vs. fractalkine + control or vehicle + Tat vs. fractalkine + Tat treatments. A similar inconsistency was observed only at 48 h with morphine treatments ( § P < 0.05).
    Mouse Striata, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse striata/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    mouse striata - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Okabe Co Ltd nscs obtained from e15 ‘green mouse’ striata
    Studies with Cx3cr1 -/- mice: Fluorescent images and effects of Cx3cr1 -/- glia on fractalkine-mediated neuroprotection . Images of the striatum (A-C) and of mixed glial cultures (D) from Cx3cr1 -/- mouse <t>striata.</t> <t>Microglia</t> within the striatum of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice fluoresce green (A,B) and are Iba-1 immunoreactive (C); Hoechst counterstained nuclei (blue); scale bars = 50 μm (A) and 10 μm (B,C). Robust GFP expression is maintained when the cells are placed into culture (D). As can be appreciated from the Hoechst stain, the CX 3 CR1-expressing population is significant although the majority of the cells in the culture lack CX 3 CR1. The loss of CX 3 CR1 on glia has a dramatic effect on the ability of fractalkine to protect morphine and Tat-treated striatal neurons (E). Neurons from the striata of wild-type mice were plated onto mixed glia prepared from Cx3cr1 -/- mouse striata and followed over 48 h using our standard paradigm. In general, wild-type neurons co-cultured with Cx3cr1 -/- glia appeared to be less viable than with wild-type glia (upper panel; compare gray and black dotted lines); however, these groups were not compared statistically since the experiments were not run concurrently. The neuroprotective effects of fractalkine (CX 3 CL1; 1 μg/ml) are abolished when wild-type neurons are co-cultured with Cx3cr1 -/- mixed glia. Under these conditions, fractalkine no longer protects neurons from combined morphine and Tat exposure (E, lower panel; * P < 0.05 vs. vehicle- or fractalkine-treated controls). There were no differences in survival between controls ± fractalkine. Addition of fractalkine did not change the toxicity of morphine, Tat, or morphine + Tat treatments. There is, however, some possibility that fractalkine enhances baseline neuron survival in the Cx3cr1 -/- glial co-cultures. This was indicated by significant differences only at 48 h between Tat + fractalkine versus control + fractalkine survival ( § P < 0.05), even though survival did not differ when comparing vehicle + control vs. fractalkine + control or vehicle + Tat vs. fractalkine + Tat treatments. A similar inconsistency was observed only at 48 h with morphine treatments ( § P < 0.05).
    Nscs Obtained From E15 ‘Green Mouse’ Striata, supplied by Okabe Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nscs obtained from e15 ‘green mouse’ striata/product/Okabe Co Ltd
    Average 90 stars, based on 1 article reviews
    nscs obtained from e15 ‘green mouse’ striata - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Charles River Laboratories striata from embryonic day 14 (e14) cd1 albino mouse embryos (plug day = 1.0)
    Studies with Cx3cr1 -/- mice: Fluorescent images and effects of Cx3cr1 -/- glia on fractalkine-mediated neuroprotection . Images of the striatum (A-C) and of mixed glial cultures (D) from Cx3cr1 -/- mouse <t>striata.</t> <t>Microglia</t> within the striatum of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice fluoresce green (A,B) and are Iba-1 immunoreactive (C); Hoechst counterstained nuclei (blue); scale bars = 50 μm (A) and 10 μm (B,C). Robust GFP expression is maintained when the cells are placed into culture (D). As can be appreciated from the Hoechst stain, the CX 3 CR1-expressing population is significant although the majority of the cells in the culture lack CX 3 CR1. The loss of CX 3 CR1 on glia has a dramatic effect on the ability of fractalkine to protect morphine and Tat-treated striatal neurons (E). Neurons from the striata of wild-type mice were plated onto mixed glia prepared from Cx3cr1 -/- mouse striata and followed over 48 h using our standard paradigm. In general, wild-type neurons co-cultured with Cx3cr1 -/- glia appeared to be less viable than with wild-type glia (upper panel; compare gray and black dotted lines); however, these groups were not compared statistically since the experiments were not run concurrently. The neuroprotective effects of fractalkine (CX 3 CL1; 1 μg/ml) are abolished when wild-type neurons are co-cultured with Cx3cr1 -/- mixed glia. Under these conditions, fractalkine no longer protects neurons from combined morphine and Tat exposure (E, lower panel; * P < 0.05 vs. vehicle- or fractalkine-treated controls). There were no differences in survival between controls ± fractalkine. Addition of fractalkine did not change the toxicity of morphine, Tat, or morphine + Tat treatments. There is, however, some possibility that fractalkine enhances baseline neuron survival in the Cx3cr1 -/- glial co-cultures. This was indicated by significant differences only at 48 h between Tat + fractalkine versus control + fractalkine survival ( § P < 0.05), even though survival did not differ when comparing vehicle + control vs. fractalkine + control or vehicle + Tat vs. fractalkine + Tat treatments. A similar inconsistency was observed only at 48 h with morphine treatments ( § P < 0.05).
    Striata From Embryonic Day 14 (E14) Cd1 Albino Mouse Embryos (Plug Day = 1.0), supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/striata from embryonic day 14 (e14) cd1 albino mouse embryos (plug day = 1.0)/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    striata from embryonic day 14 (e14) cd1 albino mouse embryos (plug day = 1.0) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Charles River Laboratories striata from e14 and e18 cd1 albino mouse embryos
    Studies with Cx3cr1 -/- mice: Fluorescent images and effects of Cx3cr1 -/- glia on fractalkine-mediated neuroprotection . Images of the striatum (A-C) and of mixed glial cultures (D) from Cx3cr1 -/- mouse <t>striata.</t> <t>Microglia</t> within the striatum of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice fluoresce green (A,B) and are Iba-1 immunoreactive (C); Hoechst counterstained nuclei (blue); scale bars = 50 μm (A) and 10 μm (B,C). Robust GFP expression is maintained when the cells are placed into culture (D). As can be appreciated from the Hoechst stain, the CX 3 CR1-expressing population is significant although the majority of the cells in the culture lack CX 3 CR1. The loss of CX 3 CR1 on glia has a dramatic effect on the ability of fractalkine to protect morphine and Tat-treated striatal neurons (E). Neurons from the striata of wild-type mice were plated onto mixed glia prepared from Cx3cr1 -/- mouse striata and followed over 48 h using our standard paradigm. In general, wild-type neurons co-cultured with Cx3cr1 -/- glia appeared to be less viable than with wild-type glia (upper panel; compare gray and black dotted lines); however, these groups were not compared statistically since the experiments were not run concurrently. The neuroprotective effects of fractalkine (CX 3 CL1; 1 μg/ml) are abolished when wild-type neurons are co-cultured with Cx3cr1 -/- mixed glia. Under these conditions, fractalkine no longer protects neurons from combined morphine and Tat exposure (E, lower panel; * P < 0.05 vs. vehicle- or fractalkine-treated controls). There were no differences in survival between controls ± fractalkine. Addition of fractalkine did not change the toxicity of morphine, Tat, or morphine + Tat treatments. There is, however, some possibility that fractalkine enhances baseline neuron survival in the Cx3cr1 -/- glial co-cultures. This was indicated by significant differences only at 48 h between Tat + fractalkine versus control + fractalkine survival ( § P < 0.05), even though survival did not differ when comparing vehicle + control vs. fractalkine + control or vehicle + Tat vs. fractalkine + Tat treatments. A similar inconsistency was observed only at 48 h with morphine treatments ( § P < 0.05).
    Striata From E14 And E18 Cd1 Albino Mouse Embryos, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/striata from e14 and e18 cd1 albino mouse embryos/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    striata from e14 and e18 cd1 albino mouse embryos - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Charles River Laboratories striata from e14 cd1 albino mouse embryos (plug day 5 1.0)
    Studies with Cx3cr1 -/- mice: Fluorescent images and effects of Cx3cr1 -/- glia on fractalkine-mediated neuroprotection . Images of the striatum (A-C) and of mixed glial cultures (D) from Cx3cr1 -/- mouse <t>striata.</t> <t>Microglia</t> within the striatum of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice fluoresce green (A,B) and are Iba-1 immunoreactive (C); Hoechst counterstained nuclei (blue); scale bars = 50 μm (A) and 10 μm (B,C). Robust GFP expression is maintained when the cells are placed into culture (D). As can be appreciated from the Hoechst stain, the CX 3 CR1-expressing population is significant although the majority of the cells in the culture lack CX 3 CR1. The loss of CX 3 CR1 on glia has a dramatic effect on the ability of fractalkine to protect morphine and Tat-treated striatal neurons (E). Neurons from the striata of wild-type mice were plated onto mixed glia prepared from Cx3cr1 -/- mouse striata and followed over 48 h using our standard paradigm. In general, wild-type neurons co-cultured with Cx3cr1 -/- glia appeared to be less viable than with wild-type glia (upper panel; compare gray and black dotted lines); however, these groups were not compared statistically since the experiments were not run concurrently. The neuroprotective effects of fractalkine (CX 3 CL1; 1 μg/ml) are abolished when wild-type neurons are co-cultured with Cx3cr1 -/- mixed glia. Under these conditions, fractalkine no longer protects neurons from combined morphine and Tat exposure (E, lower panel; * P < 0.05 vs. vehicle- or fractalkine-treated controls). There were no differences in survival between controls ± fractalkine. Addition of fractalkine did not change the toxicity of morphine, Tat, or morphine + Tat treatments. There is, however, some possibility that fractalkine enhances baseline neuron survival in the Cx3cr1 -/- glial co-cultures. This was indicated by significant differences only at 48 h between Tat + fractalkine versus control + fractalkine survival ( § P < 0.05), even though survival did not differ when comparing vehicle + control vs. fractalkine + control or vehicle + Tat vs. fractalkine + Tat treatments. A similar inconsistency was observed only at 48 h with morphine treatments ( § P < 0.05).
    Striata From E14 Cd1 Albino Mouse Embryos (Plug Day 5 1.0), supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/striata from e14 cd1 albino mouse embryos (plug day 5 1.0)/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    striata from e14 cd1 albino mouse embryos (plug day 5 1.0) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) BrdU (purple) and DAPI (blue) immunofluorescent staining of cultured adherent embryonic neural stem cells after 24 h BrdU exposure and treatment with a. PBS as vehicle, b. 20 ng/ml rhEGF as positive control and increasing doses of rmMFG-E8; c. 125 ng/ml, d. 250 ng/ml and e. 500 ng/ml. Quantification of the number of proliferating adherent embryonic stem cells (BrdU + ) showed that rmMFG-E8 increased embryonic neural stem cell proliferation in a dose-dependent manner compared with PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; #p<0.05 vs rhEGF; n = 3/group. (B) rhEGF (20 ng/ml) and rmMFG-E8 (500 ng/ml) increased neurosphere formation compared to PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; n = 3/group. Scale bar = 100 μm. (C) rmMFG-E8 treatment showed significant increase in the number of neurospheres in the <0.5 mm size categories compared to PBS. *p<0.05 vs PBS; n = 3/group.

    Journal: PLoS ONE

    Article Title: Milk Fat Globule-EGF Factor VIII Attenuates CNS Injury by Promoting Neural Stem Cell Proliferation and Migration after Cerebral Ischemia

    doi: 10.1371/journal.pone.0122833

    Figure Lengend Snippet: (A) BrdU (purple) and DAPI (blue) immunofluorescent staining of cultured adherent embryonic neural stem cells after 24 h BrdU exposure and treatment with a. PBS as vehicle, b. 20 ng/ml rhEGF as positive control and increasing doses of rmMFG-E8; c. 125 ng/ml, d. 250 ng/ml and e. 500 ng/ml. Quantification of the number of proliferating adherent embryonic stem cells (BrdU + ) showed that rmMFG-E8 increased embryonic neural stem cell proliferation in a dose-dependent manner compared with PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; #p<0.05 vs rhEGF; n = 3/group. (B) rhEGF (20 ng/ml) and rmMFG-E8 (500 ng/ml) increased neurosphere formation compared to PBS. Data are presented as mean ± SEM. *p<0.05 vs PBS; n = 3/group. Scale bar = 100 μm. (C) rmMFG-E8 treatment showed significant increase in the number of neurospheres in the <0.5 mm size categories compared to PBS. *p<0.05 vs PBS; n = 3/group.

    Article Snippet: Embryonic day-14 mouse striata neurospheres were purchased from Stem Cell Technologies (Vancouver, Canada).

    Techniques: Staining, Cell Culture, Positive Control

    Studies with Cx3cr1 -/- mice: Fluorescent images and effects of Cx3cr1 -/- glia on fractalkine-mediated neuroprotection . Images of the striatum (A-C) and of mixed glial cultures (D) from Cx3cr1 -/- mouse striata. Microglia within the striatum of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice fluoresce green (A,B) and are Iba-1 immunoreactive (C); Hoechst counterstained nuclei (blue); scale bars = 50 μm (A) and 10 μm (B,C). Robust GFP expression is maintained when the cells are placed into culture (D). As can be appreciated from the Hoechst stain, the CX 3 CR1-expressing population is significant although the majority of the cells in the culture lack CX 3 CR1. The loss of CX 3 CR1 on glia has a dramatic effect on the ability of fractalkine to protect morphine and Tat-treated striatal neurons (E). Neurons from the striata of wild-type mice were plated onto mixed glia prepared from Cx3cr1 -/- mouse striata and followed over 48 h using our standard paradigm. In general, wild-type neurons co-cultured with Cx3cr1 -/- glia appeared to be less viable than with wild-type glia (upper panel; compare gray and black dotted lines); however, these groups were not compared statistically since the experiments were not run concurrently. The neuroprotective effects of fractalkine (CX 3 CL1; 1 μg/ml) are abolished when wild-type neurons are co-cultured with Cx3cr1 -/- mixed glia. Under these conditions, fractalkine no longer protects neurons from combined morphine and Tat exposure (E, lower panel; * P < 0.05 vs. vehicle- or fractalkine-treated controls). There were no differences in survival between controls ± fractalkine. Addition of fractalkine did not change the toxicity of morphine, Tat, or morphine + Tat treatments. There is, however, some possibility that fractalkine enhances baseline neuron survival in the Cx3cr1 -/- glial co-cultures. This was indicated by significant differences only at 48 h between Tat + fractalkine versus control + fractalkine survival ( § P < 0.05), even though survival did not differ when comparing vehicle + control vs. fractalkine + control or vehicle + Tat vs. fractalkine + Tat treatments. A similar inconsistency was observed only at 48 h with morphine treatments ( § P < 0.05).

    Journal: Molecular Neurodegeneration

    Article Title: Fractalkine/CX 3 CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death

    doi: 10.1186/1750-1326-6-78

    Figure Lengend Snippet: Studies with Cx3cr1 -/- mice: Fluorescent images and effects of Cx3cr1 -/- glia on fractalkine-mediated neuroprotection . Images of the striatum (A-C) and of mixed glial cultures (D) from Cx3cr1 -/- mouse striata. Microglia within the striatum of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice fluoresce green (A,B) and are Iba-1 immunoreactive (C); Hoechst counterstained nuclei (blue); scale bars = 50 μm (A) and 10 μm (B,C). Robust GFP expression is maintained when the cells are placed into culture (D). As can be appreciated from the Hoechst stain, the CX 3 CR1-expressing population is significant although the majority of the cells in the culture lack CX 3 CR1. The loss of CX 3 CR1 on glia has a dramatic effect on the ability of fractalkine to protect morphine and Tat-treated striatal neurons (E). Neurons from the striata of wild-type mice were plated onto mixed glia prepared from Cx3cr1 -/- mouse striata and followed over 48 h using our standard paradigm. In general, wild-type neurons co-cultured with Cx3cr1 -/- glia appeared to be less viable than with wild-type glia (upper panel; compare gray and black dotted lines); however, these groups were not compared statistically since the experiments were not run concurrently. The neuroprotective effects of fractalkine (CX 3 CL1; 1 μg/ml) are abolished when wild-type neurons are co-cultured with Cx3cr1 -/- mixed glia. Under these conditions, fractalkine no longer protects neurons from combined morphine and Tat exposure (E, lower panel; * P < 0.05 vs. vehicle- or fractalkine-treated controls). There were no differences in survival between controls ± fractalkine. Addition of fractalkine did not change the toxicity of morphine, Tat, or morphine + Tat treatments. There is, however, some possibility that fractalkine enhances baseline neuron survival in the Cx3cr1 -/- glial co-cultures. This was indicated by significant differences only at 48 h between Tat + fractalkine versus control + fractalkine survival ( § P < 0.05), even though survival did not differ when comparing vehicle + control vs. fractalkine + control or vehicle + Tat vs. fractalkine + Tat treatments. A similar inconsistency was observed only at 48 h with morphine treatments ( § P < 0.05).

    Article Snippet: Mixed glial (astroglia and microglia) cultures were prepared from neonatal (P0-P1) wild-type ICR or Cx3cr1 -/- mouse striata (Charles River) as previously described [ ].

    Techniques: Expressing, Staining, Cell Culture, Control

    Effects of morphine and/or HIV-1 Tat exposure ± fractalkine on the percentage of  microglia  in mixed-glia cultures from  striata  of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice ( ‡ ).

    Journal: Molecular Neurodegeneration

    Article Title: Fractalkine/CX 3 CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death

    doi: 10.1186/1750-1326-6-78

    Figure Lengend Snippet: Effects of morphine and/or HIV-1 Tat exposure ± fractalkine on the percentage of microglia in mixed-glia cultures from striata of Cx3cr1 -/- ( Cx3cr1 GFP/GFP ) mice ( ‡ ).

    Article Snippet: Mixed glial (astroglia and microglia) cultures were prepared from neonatal (P0-P1) wild-type ICR or Cx3cr1 -/- mouse striata (Charles River) as previously described [ ].

    Techniques: Mouse Assay, Control